NEOADJUVANT CHEMOTHERAPY
Clinical trials for NEOADJUVANT CHEMOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT CHEMOTHERAPY trials appear
Sign up with your email to follow new studies for NEOADJUVANT CHEMOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Ovarian cancer trial uses KELIM score to personalize surgery timing
Disease control Not yet recruitingThis study looks at whether a blood test score (KELIM) can help doctors decide the best time for surgery in people with advanced ovarian cancer. After three rounds of chemotherapy, patients with a good score will have surgery sooner, while those with a poor score will get more ch…
Matched conditions: NEOADJUVANT CHEMOTHERAPY
Phase: NA • Sponsor: Aristotle University Of Thessaloniki • Aim: Disease control
Last updated May 26, 2026 03:10 UTC
-
Could chemo before surgery beat standard care for colon cancer?
Disease control Not yet recruitingThis study compares giving chemotherapy before surgery versus surgery alone for people with stage II or III colon cancer that has a high chance of coming back. About 100 adults aged 18-70 will be randomly assigned to one of two groups. The goal is to see if pre-surgery chemo impr…
Matched conditions: NEOADJUVANT CHEMOTHERAPY
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New ultrasound method may spare breast cancer patients unnecessary surgery
Diagnosis Not yet recruitingThis study looks at whether a special ultrasound can accurately tell if breast cancer has been completely cleared from the lymph nodes after chemotherapy. About 150 women with breast cancer that has spread to their lymph nodes will have a tiny marker placed in the affected node b…
Matched conditions: NEOADJUVANT CHEMOTHERAPY
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Diagnosis
Last updated May 26, 2026 03:03 UTC
-
Tiny heart sensor could predict cancer surgery outcomes
Knowledge-focused Not yet recruitingThis study tests a small, smartphone-sized device called Seismofit that measures heart vibrations to estimate fitness in oesophageal cancer patients. Researchers want to see if this quick, rest-based test can predict complications like pneumonia and hospital stay length after che…
Matched conditions: NEOADJUVANT CHEMOTHERAPY
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC